Borderline COVID-19 PCR Test Result

Follow-up of patients with a borderline PCR result. Data of patients that were re-tested within 96 hours after receiving a borderline COVID-19 PCR result are reviewed.

This is a retrospective study.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Covid19 COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Virus Diseases

Sex eligibility

All sexes

Study type

Observational

Primary location

Clinical Laboratory Jessa Hospital

Hasselt, Limburg, 3500, Belgium

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Every individual that delivers a nasopharyngeal lysate for SARS-CoV-2 RNA determination by PCR.

Exclusion criteria

Patients without a previous borderline COVID-19 PCR result within 96 hours are excluded for the follow-up study.

Treatment and study plan

SARS-CoV-2 PCR

Diagnostic Test

SARS-CoV-2 PCR of nasopharyngeal lysate.

Primary outcomes

Ratio of positivity conversion after receiving a COVID-19 borderline PCR result.

Time frame: 3 days

Secondary outcomes

Symptoms predicting COVID-19 positivity conversion after receiving a borderline PCR result.

Time frame: 1 day

Sponsors and collaborators

Lead sponsor

Jessa Hospital

Other

Registry information

Official study title

Follow-up of Patients With a Borderline COVID-19 PCR Test Result

Important dates

Study start: 2020
Primary completion: 2021
Study completion: 2021
First posted: Nov 19, 2020
Registry last updated: Feb 16, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed